ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
Molecular Genetics and Metabolism
Volume 88, Issue 2, June 2006, Pages 138-145
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Article
Purchase PDF (538 K)

 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/j.ymgme.2006.02.007    How to Cite or Link Using DOI (Opens New Window)
Copyright © 2006 Elsevier Inc. All rights reserved.

Subacute combined degeneration of the spinal cord in cblC disorder despite treatment with B12

Sharon E. Smitha, c, Hannah C. Kinneyb, d, Kathryn J. Swobodae and Harvey L. Levya, c, Corresponding Author Contact Information, E-mail The Corresponding Author

aDivision of Genetics, Children’s Hospital Boston, MA 02115, USA bDepartment of Pathology (Neuropathology), Children’s Hospital Boston, MA 02115, USA cDepartment of Pediatrics, Harvard Medical School, USA dDepartment of Pathology, Harvard Medical School, USA eDepartment of Neurology, University of Utah School of Medicine, Salt Lake City, UT 84132, USA

Received 22 November 2005; 
revised 13 February 2006; 
accepted 14 February 2006. 
Available online 30 March 2006.

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Abstract

Subacute combined degeneration (SCD) of the spinal cord is a characteristic complication of vitamin B12 deficiency, but it has never been neuropathologically demonstrated in a B12-inborn error of metabolism. In this report SCD is documented in a 15-year-old boy with early-onset cobalamin C (cblC) disorder. The neuropathologic findings included multifocal demyelination and vacuolation with predilection for the dorsal and lateral columns at the mid-thoracic level of the spinal cord, confirming the similarity of SCD in cblC disorder to the classic adult SCD due to vitamin B12 deficiency. SCD developed in this boy despite treatment for cblC disorder that began at 3 months of age. There is clinical and experimental evidence to suggest that a deficiency in remethylation with concomitant reduction in brain methionine may be the cause of SCD. In this patient plasma methionine levels were low without betaine and/or l-methionine supplementation and in the normal range for only a 2-year period during compliance with therapy. In cblC disorder, a consistent increase in blood methionine to high normal or above normal levels by the use of betaine and l-methionine supplementation may be helpful in preventing SCD. This is especially important now that the presymptomatic detection of cblC disorder is possible through the expansion of newborn screening.

Keywords: Cobalamin; cblC disorder; Subacute combined degeneration; Peripheral neuropathy; Neuropathology; Myelopathy; Demyelination; Methionine; Remethylation; Inborn errors of metabolism; Methylmalonic acid; Homocysteine; Homocystinuria; Methylmalonic acidemia

Article Outline

Introduction
Case report
Autopsy findings
Systemic pathology
Brain and spinal cord
Skeletal muscle
Peripheral nerve
Discussion
Acknowledgements
References





 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.